OBJECTIVES: To characterise the phenotype of the putative dendritic cells strongly expressing Jak3 and STAT4, which have been previously identified in the synovial tissue of patients with active rheumatoid arthritis (RA). METHODS: Synovial biopsy specimens were obtained at arthroscopy from 30 patients with active RA (42 synovial biopsies). Immunohistological analysis was performed using monoclonal antibodies to detect dendritic cell subsets, including activation markers and cytokines relevant to dendritic cell function. Co-localisation of cell surface markers and cytokines was assessed primarily using sequential sections, with results confirmed by dual immunohistochemistry and immunofluorescence with confocal microscopy. RESULTS: The dendritic cells identified in RA synovial tissue that strongly express Jak3 also strongly express STAT4 and STAT 6 and are correlated with the presence of serum rheumatoid factor. These cells are not confined to a single dendritic cell subset, with cells having phenotypes consistent with both myeloid- and plasmacytoid-type dendritic cells. The activation status of these dendritic cells suggests that they are maturing or mature dendritic cells. These dendritic cells produce IL12 as well as interferon alpha and gamma. CONCLUSIONS: The close correlation of these dendritic cells with the presence of serum rheumatoid factor, a prognostic factor for worse disease outcome, and the strong expression by these cells of components of the Jak/STAT transcription factor pathway suggest a potential therapeutic target for the treatment of RA.
OBJECTIVES: To characterise the phenotype of the putative dendritic cells strongly expressing Jak3 and STAT4, which have been previously identified in the synovial tissue of patients with active rheumatoid arthritis (RA). METHODS: Synovial biopsy specimens were obtained at arthroscopy from 30 patients with active RA (42 synovial biopsies). Immunohistological analysis was performed using monoclonal antibodies to detect dendritic cell subsets, including activation markers and cytokines relevant to dendritic cell function. Co-localisation of cell surface markers and cytokines was assessed primarily using sequential sections, with results confirmed by dual immunohistochemistry and immunofluorescence with confocal microscopy. RESULTS: The dendritic cells identified in RA synovial tissue that strongly express Jak3 also strongly express STAT4 and STAT 6 and are correlated with the presence of serum rheumatoid factor. These cells are not confined to a single dendritic cell subset, with cells having phenotypes consistent with both myeloid- and plasmacytoid-type dendritic cells. The activation status of these dendritic cells suggests that they are maturing or mature dendritic cells. These dendritic cells produce IL12 as well as interferon alpha and gamma. CONCLUSIONS: The close correlation of these dendritic cells with the presence of serum rheumatoid factor, a prognostic factor for worse disease outcome, and the strong expression by these cells of components of the Jak/STAT transcription factor pathway suggest a potential therapeutic target for the treatment of RA.
Authors: Svetlana N Bykovskaia; Galina V Shurin; Scott Graner; Mark L Bunker; Walter Olson; Ronald Thomas; Michael R Shurin; Stanley Marks; Walter J Storkus; Jeffrey Shogan Journal: Stem Cells Date: 2002 Impact factor: 6.277
Authors: A Dzionek; Y Sohma; J Nagafune; M Cella; M Colonna; F Facchetti; G Günther; I Johnston; A Lanzavecchia; T Nagasaka; T Okada; W Vermi; G Winkels; T Yamamoto; M Zysk; Y Yamaguchi; J Schmitz Journal: J Exp Med Date: 2001-12-17 Impact factor: 14.307
Authors: Lois L Cavanagh; Amanda Boyce; Louise Smith; Jagadish Padmanabha; Luis Filgueira; Peter Pietschmann; Ranjeny Thomas Journal: Arthritis Res Ther Date: 2005-01-11 Impact factor: 5.156
Authors: Saedis Saevarsdottir; Lilja Stefansdottir; Patrick Sulem; Gudmar Thorleifsson; Egil Ferkingstad; Gudrun Rutsdottir; Bente Glintborg; Helga Westerlind; Gerdur Grondal; Isabella C Loft; Signe Bek Sorensen; Benedicte A Lie; Mikael Brink; Lisbeth Ärlestig; Asgeir Orn Arnthorsson; Eva Baecklund; Karina Banasik; Steffen Bank; Lena I Bjorkman; Torkell Ellingsen; Christian Erikstrup; Oleksandr Frei; Inger Gjertsson; Daniel F Gudbjartsson; Sigurjon A Gudjonsson; Gisli H Halldorsson; Oliver Hendricks; Jan Hillert; Estrid Hogdall; Søren Jacobsen; Dorte Vendelbo Jensen; Helgi Jonsson; Alf Kastbom; Ingrid Kockum; Salome Kristensen; Helga Kristjansdottir; Margit H Larsen; Asta Linauskas; Ellen-Margrethe Hauge; Anne G Loft; Bjorn R Ludviksson; Sigrun H Lund; Thorsteinn Markusson; Gisli Masson; Pall Melsted; Kristjan H S Moore; Heidi Munk; Kaspar R Nielsen; Gudmundur L Norddahl; Asmundur Oddsson; Thorunn A Olafsdottir; Pall I Olason; Tomas Olsson; Sisse Rye Ostrowski; Kim Hørslev-Petersen; Solvi Rognvaldsson; Helga Sanner; Gilad N Silberberg; Hreinn Stefansson; Erik Sørensen; Inge J Sørensen; Carl Turesson; Thomas Bergman; Lars Alfredsson; Tore K Kvien; Søren Brunak; Kristján Steinsson; Vibeke Andersen; Ole A Andreassen; Solbritt Rantapää-Dahlqvist; Merete Lund Hetland; Lars Klareskog; Johan Askling; Leonid Padyukov; Ole Bv Pedersen; Unnur Thorsteinsdottir; Ingileif Jonsdottir; Kari Stefansson Journal: Ann Rheum Dis Date: 2022-04-25 Impact factor: 27.973
Authors: K Juczynska; A Wozniacka; E Waszczykowska; M Danilewicz; M Wagrowska-Danilewicz; J Wieczfinska; R Pawliczak; A Zebrowska Journal: Mediators Inflamm Date: 2017-10-24 Impact factor: 4.711